This brand name is authorized in Canada, United States
The drug KINEVAC contains one active pharmaceutical ingredient (API):
|
1
Sincalide
UNII M03GIQ7Z6P - SINCALIDE
|
|
Sincalide is a cholecystopancreatic-gastrointestinal hormone peptide for parenteral administration. The agent is a synthetically-prepared C-terminal octapeptide of cholecystokinin. When injected intravenously, sincalide stimulates gallbladder contraction and reduction in size. The evacuation of bile that results is similar to that which occurs physiologically in response to endogenous cholecystokinin. Sincalide also stimulates pancreatic secretion and intestinal motility causing pyloric contraction and slows gastric emptying. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| KINEVAC Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CC03 | Sincalide | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CC Tests for bile duct patency |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02228602 |
| Country: US | FDA, National Drug Code | Identifier(s): 0270-0556 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
